GNPX

Conviction 0HealthcareScan · Thu, Sep 24, 2026

Genprex, Inc. (GNPX) closed at $3.51 (-6.40%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 39, RS Rating 1, -99.4% from its 52-week high, -87.7% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

GNPX$3.51-6.40%

ResistanceSupportVol 14Insider sellCongress buyCongress sell

Vol MA14 239.21K

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Genprex, Inc.PHARMACEUTICAL PREPARATIONSwww.genprex.com ↗

Price3.51

Change-6.40%

Gap-8.27%

Rel volume—

Avg volume188.65K

Avg $ vol692.4K

SMA 203.50

SMA 504.73

SMA 20019.75

Price vs 50-25.87%

Price vs 200-82.23%

MA stackbearish

50/200 cross—

Supertrenddown · 4.12

RSI (14)39

MACD hist0.13

MACD cross—

Stoch %K / %D27 / 50

ADX (14)25

+DI / −DI25 / 18

RSI divergenceBullish

MACD divergenceBullish

ATR %9.60%

ADR %6.32%

52w high537.60

52w low3.31

From 52w high-99.35%

Above 52w low+6.04%

New 52w highNo

SqueezeOn · 8d

Bollinger width13.04%

%B0.52

Donchian pos26.60%

Donchian high4.20

Donchian low3.26

AVWAP (52w high)50.68

vs AVWAP high-93.07%

AVWAP (52w low)3.73

vs AVWAP low-5.88%

OBV trendUp

Chaikin MF (20)-0.16

Today vs 20d—

Avg vol (14d)239.21K

Avg vol (20d)188.65K

Avg $ vol (20d)692.4K

Market cap2.88M

RS Rating1 / 99

RS 3m (vs SPY)-57.92%

RS 6m (vs SPY)-105.51%

RS line new highNo

Trend template0/8

Technical rank10.0

1 week+1.45%

1 month-12.25%

3 months-53.43%

6 months-88.69%

1 year-97.51%

YTD-87.74%

P/E-0.18

P/B0.19

P/S—

P/FCF-0.19

EPS-0.4200

Div yield—

ROE-109.69%

ROA-94.70%

Debt/Eq—

Current6.77

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth23.13%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-12.28M

Revenue0

Net income-4.45M

Gross profit—

Free cash flow-15.31M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out10.93M

Employees13

ListedThu, Mar 29, 2018

Free float40.4M

Float %94.2%

Short interest85.86K

Days to cover0.2d

Short volume56.0%

Squeeze score12 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank10.0 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.76

Support3.29

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in GNPX · 1 recent

All disclosures →

Member	Side	Amount	Traded	Filed	PTR
Tim Moore house · NC · traded 2025-12-18	Buy	$1K–$15K	2025-12-18	2026-01-03	PDF

Insider activity

SEC Form 4 transactions in GNPX · open-market 2 sells

Insider	Side	Shares	Value	Traded	Filed
LONGNECKER BRENT M Director · Common Stock · 2026-04-14	Sell	10	$12	2026-04-14	2026-04-15
LONGNECKER BRENT M Director · Common Stock · 2026-04-14	Sell	8	$10	2026-04-14	2026-04-15

SEC filings

EDGAR filings in GNPX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.